Biomind Labs Inc (BMND) — Cash Flow-to-Debt Ratio
Biomind Labs Inc (BMND) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of CA$-65.95K could theoretically repay 0% of its total liabilities (CA$1.83 Million) in one year. See Biomind Labs Inc (BMND) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Biomind Labs Inc Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Biomind Labs Inc across 5 annual periods. For the full cash flow conversion analysis, see Biomind Labs Inc (BMND) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Biomind Labs Inc (2021–2025)
Year-by-year debt coverage analysis for Biomind Labs Inc. Check Biomind Labs Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.04x | CA$-67.55K | CA$1.74 Million | ▲ +85.3% |
| 2024 | -0.26x | CA$-354.43K | CA$1.34 Million | ▲ +48.0% |
| 2023 | -0.51x | CA$-765.93K | CA$1.51 Million | ▲ +92.0% |
| 2022 | -6.39x | CA$-2.15 Million | CA$336.72K | ▼ -0.8% |
| 2021 | -6.34x | CA$-2.12 Million | CA$334.95K | — |